ARCHIVES

NCI To Stop All Support For WHT After March 31

This article is from The Cancer Letter archive.

Vol. 14 No. 06 | February 5, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Needs Staff, Funds But first Must Determine Priorities, GAO Says

November 17, 1989

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

July 13, 2007

Minority Demonstration Centers Concept

May 12, 1989

Two Drugs Combined Better Than One Alone, Study Finds

February 27, 2009

Cooperative group chairman suggest changes to incentive system.

August 13, 2004